Related Experiment Video
Updated: Jan 17, 2026

Echocardiographic Assessment Using Subxiphoid-Only Examination for Hypotensive Patients
Published on: April 18, 2025
Viewpoint on the 2025 Focused Update of the 2019 ESC/EAS Guidelines for the Management of Dyslipidaemias
Kapka Miteva1, Aliki Buhayer1, Cédric Follonier2
1Department of Cardiology, Foundation for Medical Research, Faculty of Medicine, University of Geneva.
Abstract:
The 2025 Focused Update of the 2019 ESC/EAS Guidelines for the management of dyslipidaemias incorporates significant new evidence from major randomized controlled trials, as well as relevant systematic reviews and meta-analyses published since 2019 and up until 31 March 2025. The Update targets specific areas in which new data on prognostics models, diagnostic accuracy studies and therapeutics, including assessment of risk-benefit ratios, could immediately influence clinical practice, providing revised or new recommendations.
Related Concept Videos
Atherosclerosis III: Management
Lipid-Lowering Drugs: Statins and Miscellaneous Agents
Angina IV: Management
Atherosclerosis IV: Nursing Management
Overview of Lipid Metabolism
Lipolysis: The Breakdown of Lipids:
Lipolysis is the process of breaking down lipids, particularly triglycerides, into glycerol and fatty acids. This process typically occurs in the adipose tissue and is triggered by various hormones, including glucagon and...
Coronary Artery Disease IV: Preventive Measures

